Syndax Pharmaceuticals (SNDX) PT Lowered to $30 at BofA Securities
Tweet Send to a Friend
BofA Securities analyst Jason Zemansky lowered the price target on Syndax Pharmaceuticals (NASDAQ: SNDX) to $30.00 (from $31.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
